azd2014
Showing 1 - 13 of 13
Advanced Solid Malignancies Trial in Chuo-ku, Kashiwa (AZD2014)
Active, not recruiting
- Advanced Solid Malignancies
- AZD2014
-
Chuo-ku, Japan
- +1 more
Feb 2, 2023
Meningioma Trial in Chicago, Boston (AZD2014)
Active, not recruiting
- Meningioma
- AZD2014
-
Chicago, Illinois
- +2 more
Oct 15, 2022
NSCLC Metastatic Trial in France (AZD2014, AZD4547, AZD5363)
Active, not recruiting
- Non-small Cell Lung Cancer Metastatic
- AZD2014
- +10 more
-
Avignon, France
- +36 more
Jul 29, 2022
Metastatic Breast Cancer Trial in France (AZD2014, AZD4547, AZD5363)
Active, not recruiting
- Metastatic Breast Cancer
- AZD2014
- +18 more
-
Angers, France
- +24 more
Mar 8, 2022
Glioblastoma Multiforme Trial in Canada (AZD2014)
Completed
- Glioblastoma Multiforme
- AZD2014
-
Calgary, Alberta, Canada
- +3 more
Apr 7, 2020
Prostate Cancer Trial in Cambridge (AZD2014)
Completed
- Prostate Cancer
- AZD2014
-
Cambridge, Cambridgeshire, United KingdomCambridge University Hospitals NHS Foundation Trust
Jul 15, 2019
Stomach Tumors Trial in Seoul (AZD2014)
Terminated
- Stomach Neoplasms
- AZD2014
-
Seoul, Korea, Republic ofSamsung Medical Center
May 17, 2019
Cancer of Stomach Trial in Seoul (AZD2014)
Terminated
- Cancer of Stomach
- AZD2014
-
Seoul, Korea, Republic ofSamsung Medical Center
May 17, 2019
Advanced Gastric Adenocarcinoma Trial in Seoul (AZD5363, paclitaxel, AZD2014)
Terminated
- Advanced Gastric Adenocarcinoma
- AZD5363
- +2 more
-
Seoul, Korea, Republic ofSamsung Medical center
May 17, 2019
Estrogen Receptor Positive Breast Cancer Trial in Worldwide (AZD2014, Everolimus, Fulvestrant)
Unknown status
- Estrogen Receptor Positive Breast Cancer
- AZD2014
- +2 more
-
Angers, France
- +78 more
Feb 24, 2020
Core: Relapsed or Refractory DLBCL, Module 1: Non-GCB DLBCL Trial (AZD2014, Ibrutinib)
Withdrawn
- Core: Relapsed or Refractory Diffuse Large B-Cell Lymphoma
- Module 1: Non-GCB Diffuse Large B-Cell Lymphoma
- AZD2014
- Ibrutinib
- (no location specified)
Sep 14, 2016
Advanced Solid Malignancies Trial in Manchester, Sutton (AZD2014)
Completed
- Advanced Solid Malignancies
- AZD2014
-
Manchester, United Kingdom
- +1 more
Jan 13, 2016
Metastatic Clear Cell Renal Carcinoma Trial in United Kingdom (AZD2014, Everolimus)
Terminated
- Metastatic Clear Cell Renal Carcinoma
- AZD2014
- Everolimus
-
Bournemouth, United Kingdom
- +8 more
Jun 23, 2014